Oxford Biomedica Statistics
Total Valuation
OXBDF has a market cap or net worth of 408.88 million. The enterprise value is 477.45 million.
| Market Cap | 408.88M |
| Enterprise Value | 477.45M |
Important Dates
The next estimated earnings date is Monday, June 23, 2025.
| Earnings Date | Jun 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 106.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +7.15% |
| Shares Change (QoQ) | -3.30% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 56.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.54 |
| PB Ratio | 5.40 |
| P/TBV Ratio | 11.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.83 |
| EV / Sales | 2.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.56 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 1.80.
| Current Ratio | 2.28 |
| Quick Ratio | 1.98 |
| Debt / Equity | 1.80 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.87 |
| Interest Coverage | -3.84 |
Financial Efficiency
Return on equity (ROE) is -70.28% and return on invested capital (ROIC) is -13.18%.
| Return on Equity (ROE) | -70.28% |
| Return on Assets (ROA) | -9.76% |
| Return on Invested Capital (ROIC) | -13.18% |
| Return on Capital Employed (ROCE) | -21.81% |
| Revenue Per Employee | 189,699 |
| Profits Per Employee | -63,613 |
| Employee Count | 850 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.94% in the last 52 weeks. The beta is 0.96, so OXBDF's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +34.94% |
| 50-Day Moving Average | 4.72 |
| 200-Day Moving Average | 4.19 |
| Relative Strength Index (RSI) | 43.91 |
| Average Volume (20 Days) | 12,796 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OXBDF had revenue of 161.24 million and -54.07 million in losses. Loss per share was -0.52.
| Revenue | 161.24M |
| Gross Profit | 66.38M |
| Operating Income | -47.33M |
| Pretax Income | -59.17M |
| Net Income | -54.07M |
| EBITDA | -26.15M |
| EBIT | -47.33M |
| Loss Per Share | -0.52 |
Balance Sheet
The company has 75.93 million in cash and 136.16 million in debt, giving a net cash position of -60.23 million.
| Cash & Cash Equivalents | 75.93M |
| Total Debt | 136.16M |
| Net Cash | -60.23M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 75.73M |
| Book Value Per Share | 0.67 |
| Working Capital | 93.74M |
Cash Flow
In the last 12 months, operating cash flow was -63.43 million and capital expenditures -9.38 million, giving a free cash flow of -72.81 million.
| Operating Cash Flow | -63.43M |
| Capital Expenditures | -9.38M |
| Free Cash Flow | -72.81M |
| FCF Per Share | n/a |
Margins
Gross margin is 41.17%, with operating and profit margins of -29.35% and -33.53%.
| Gross Margin | 41.17% |
| Operating Margin | -29.35% |
| Pretax Margin | -36.70% |
| Profit Margin | -33.53% |
| EBITDA Margin | -16.22% |
| EBIT Margin | -29.35% |
| FCF Margin | n/a |
Dividends & Yields
OXBDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.15% |
| Shareholder Yield | -7.15% |
| Earnings Yield | -13.22% |
| FCF Yield | -17.81% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OXBDF has an Altman Z-Score of -0.89. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.89 |
| Piotroski F-Score | n/a |